• Local Treatment of Diabetic Foot Ulcers by Hyperoil™: An Unexpected Outcome
    Ahmed Salah Arafa *, Ahmed yehia , Alaa fiad
  • Evaluation of the Effect of Pulsed Electromagnetic Field Therapy in the Treatment of Chronic Wounds
    1Magdy Salah El-Din Hussain, 1Hisham Wefky Anwar, 2Mostafa Mahmoud El Nakib, 1Amr Essam Mosaad*
  • Sandwich Vacuum Bogota versus Conventional Bogota Bag as Temporary Abdominal Closure (TAC) Techniques
    Doaa Ahmed Mansour M.D., FRCS Eng
  • Bleomycin Sclerotherapy for Management of Cervicofacial and Axillary Lymphatic Malformations in Children
    Moutaz Ragab1,Mohamed Hamed Abouelfadl1, Mahmoud M. Marei 1
  • Efficacy and Safety of Systemic Beta Blockers for the Treatment of Infantile Hemangioma
    Moutaz Ragab, Mahmoud M. Marei ,Mohamed Hamed Abouelfadl
  • Comparison between Mass Ligation of Testicular Vessels versus Testicular Artery Sparing during Laparoscopic Bilateral Varicocelectomy
    Wadie Boshra MD, MRCS, Mohammed Attia Elsayed MD, Ahmed S. M. Omar MD.
  • Study of Splenic Injury in Belharzail Hepatic Fibrosis Patients Subjected To Blunt Abdominal Trauma
    Mahmoud Alhussinia, M. Ashraf Balbaab, Ahmed Tarek Awada, Tamer Abdelbakia
  • Choledochal Cysts in Adults: The Clinicopathological Features and Surgical Outcomes in a Single Institute.
    Ahmed El-Gendi1, Mohamed El-Shafei2, Essam Bedewy3
  • Banded Versus Non-Banded Sleeve Gastrectomy “Comparative Study”
    Elsobky A, MD
  • Ultrasound guided sclerotherapy injection of subulcer venous plexus for treatment of chronic venous ulcer
    Ahmed Sawaby1, Islam Atta2, Amr El Abd3,Mohsen Ahmed Abdelmohsen4
  • Impact of Roux-en-Y gastric bypass and sleeve gastrectomy on three common co-morbidities in morbidly obese Egyptian patients: A randomized comparative study
    Ayman M. A. Osman1 MD, MRCS (Eng); Hytham H. Mohey1 M.Sc.; Ahmed M. Ghobashy1 MD
  • Is transfer of surgically risk necrotizing enterocolitis to tertiary center is important from the start?
    Nezar A. Abo Halawa1*, Ahmed El-Abd Ahmed2, Sawsan A. Elkhateeb3, Galal H. Galal3
  • Delayed Primary Closure of Exomphalos Major in a Limited Resource Area
    Nezar A. Abo Halawa1*, Mohamed Yousef Batikhe2
  • Bilateral Thoracoscopic Sympathectomy for Primary Palmar Hyperhidrosis, Which Level: T3 or T4?
    Wadie Boshra MD, MRCS, Abdallah Hamed Ibrahim Khalil MD, Fawzy Salah Fawzy MD, MRCS
  • Comparative study between Tunneled central venous catheter and Infraclavicular Arterio-arterial Prosthetic loop as an access for Hemodialysis in End stage renal disease (ESRD)
    Hussein Ali Mustafa Abdel-Motaleb, Mohammed Ahmed Mohammed Ismail, Islam Mohamed Nabil Atta & Ahmed Mohammed Ahmed Abdel-Rahim*
  • Significance of Metastatic Positive Lateral Group of Lymph Nodes in Patients Undergoing Axillary Dissection for Breast Carcinoma
    Reem Mohamed Ali Abd El Reheem El Masry1, Sameh Abd Allah Maaty2, Anwar A. El Shenawy3, Fawzy Salah Fawzy2
  • Efficacy and Safety of Systemic Beta Blockers for the Treatment of Infantile Hemangioma

    Moutaz Ragab, Mahmoud M. Marei ,Mohamed Hamed Abouelfadl
    Department of Surgery, Pediatric Surgery Unit, Cairo University Specialized Pediatric Hospital (CUSPH), Faculty of Medicine, Cairo University, Cairo, Egypt.

    Background: Infantile hemangiomas (IHs) are the commonest soft tissue tumors of infancy, with an incidence of 4% to 10% of children. Despite showing spontaneous regression following the initial proliferative phase, about 30% of cases may ulcerate, show massive growth, cause disfigurement or impact normal developmentor appearance. Common locations for problematic hemangiomas include the face, ear, orbit and airways. These hemangiomas may subsequently require early and aggressive treatment,to achieve ideal functional and cosmetic outcomes. In this study, we present the efficacy of oral propranolol in infants younger than 24 months of age, with infantile hemangiomas. This prospective cohort included 32 patients with infantile hemangiomas, attending the vascular anomalies’ outpatient clinic at Cairo University Specialized Pediatric Hospital, between June 2016 and June 2018, who were treated with oral propranolol. Patients were evaluated after 7 days of treatment and then every month for a minimum of 6 months. Monthly evaluation consisted of clinical and photographic evaluations of the lesions and monitoring of treatment compliance and tolerance. Results: The mean age of patients was 5.48 months at the point of starting the treatment (range: 3-12 months) and was 11.64 months (range: 9-18 months) at the time of stopping the treatment. Eight males and 24 females (M:F = 1:3) were included in the study. The mean reduction of the lesion size was 36.85% (SD 11.9).Complications recorded in this study were as follows, 2 cases developed hypoglycemia (6.25%), 2 cases developed relapse after stopping the medication (6.25%) and 1 case developed hyperactivity/reactivity of the airways (3.2%). Twenty-seven cases (84%) suffered no complications, and the treatment was well tolerated in these. Conclusion: Propranolol is the 1st line of treatment in IHs. It is safe and well tolerated with minimal side effects. Keywords: Infantile Hemangioma; Oral Propranolol; Beta Blockers.